EUROFINS SCIENTIFIC SE Financial comparisons Eurofins Scientific SE
Equities
ERF
FR0014000MR3
Healthcare Facilities & Services
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.08 EUR | -0.72% |
|
-1.25% | -11.70% |
| 09-02 | Eurofins Scientific: new share buyback program | CF |
| 09-02 | Eurofins Scientific Launches New Share Buyback Program | MT |
Main competitors
| Revenues ($) (Y-1) | Net margin (Y-1) | Operating Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Debt/EBITDA) (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 7.19B | +4.76% | +12.92% | +6.29% | +2.96% | 1.98x | ||
| 64.97B | +8.07% | +14.85% | +364.75% | +9.46% | 3.04x | ||
| 358B | +2.33% | +4.90% | +15.24% | +4.72% | 2.51x | ||
| 2.53B | +21.52% | +22.04% | +33.10% | +14.42% | 1.06x | ||
| 24.61B | -2.66% | +10.14% | +7.90% | +2.47% | 3.88x | ||
| 12.16B | +3.44% | +14.10% | +13.22% | +6.44% | 2.18x | ||
| 9.25B | +9.23% | +15.75% | +14.00% | +6.36% | 2.34x | ||
| 1.08B | -40.16% | -41.22% | -59.11% | -30.66% | 1.25x | ||
| 14.28B | +5.03% | +8.23% | +11.89% | +5.23% | 2.75x | ||
| 20.55B | +2.97% | +13.00% | +44.44% | +2.20% | 3.89x | ||
| 8.21B | +4.50% | +9.66% | +9.52% | +2.37% | 0.87x | ||
| 12.14B | +5.70% | +14.28% | +89.23% | +4.67% | 3.2x | ||
| 21.47B | +2.57% | +7.04% | +4.99% | +2.17% | 3.45x | ||
| 4.46B | +5.88% | - | - | - | - | ||
| 644M | +19.56% | +23.07% | +13.37% | +9.57% | 0.13x | ||
| 2.26B | +12.03% | +17.39% | +32.36% | - | - | ||
| 2.93B | -0.74% | +18.62% | +11.45% | +6.19% | 1.88x | ||
| 756M | +27.61% | +32.71% | +31.80% | +26.20% | -1.13x | ||
| Average | 31.52B | +5.09% | +11.62% | +37.91% | +4.67% | 2.08x | |
| Weighted average by Cap. | 87.42B | +5.07% | +10.82% | +107.83% | +5.52% | 2.45x |
- Stock Market
- Equities
- ERF Stock
- Sector Eurofins Scientific SE
- Financial comparisons
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition